Editorial: Recent advances in small molecule-based targeted therapy for breast cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Thet Thet,Htar

第一单位： School of Pharmacy, Monash University Malaysia, Subang Jaya, Selangor, Malaysia.

作者： Thet Thet,Htar ^[1] ; Rakesh,Naidu ^[2] ; Vuanghao,Lim ^[3] ; Amit Kumar,Pandey ^[4]

作者单位： School of Pharmacy, Monash University Malaysia, Subang Jaya, Selangor, Malaysia. ^[1] Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Subang Jaya, Selangor, Malaysia. ^[2] Advanced Medical and Dental Institute, Universiti Sains Malaysia, Kepala Batas, Penang, Malaysia. ^[3] Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER-Ahmedabad), Gandhinagar, Gujarat, India. ^[4]

关键词 breast cancer drug design inhibitors small molecules targeted therapy

DOI 10.3389/fphar.2023.1343664

PMID 38192413

发布时间 2024-01-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in pharmacology

2023年14卷

1343664页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Editorial: Recent advances in small molecule-based targeted therapy for breast cancer.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Editorial: Recent advances in small molecule-based targeted therapy for breast cancer.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除